Islet Transplantation and Kidney Health: What a 20-Year Study Reveals
A major study tracking kidney function in islet transplant recipients shows that while immunosuppressive drugs do affect the kidneys, the decline slows significantly after the first year. Understanding these patterns may help inform safer transplant strategies.
Evidence label explains the kind of source behind this article (for example peer-reviewed literature vs community video). It is not medical advice.
Key takeaways
- Kidney function drops most sharply in the first year after islet transplantation, then stabilizes considerably in the years that follow
- Women experienced a steeper decline in kidney function during that critical first year compared to men
- The immunosuppressive drugs used to prevent transplant rejection—specifically calcineurin inhibitors—play a role in kidney stress, motivating research into alternatives
- Long-term islet transplant outcomes depend on careful monitoring and management of kidney health alongside transplant function
Why Kidney Health Matters After Islet Transplant
Islet transplantation is an established treatment option for people with Type 1 diabetes who experience severe, life-threatening low blood sugar episodes that are hard to prevent. During the procedure, insulin-producing cells from a donor pancreas are infused into the liver, where they can produce insulin to help regulate blood sugar.
To keep the transplanted islets from being rejected, recipients must take immunosuppressive medications—drugs that calm the immune system. However, one class of these drugs, calcineurin inhibitors, can stress the kidneys over time. Understanding how islet transplantation affects kidney function helps doctors and patients make informed decisions about this treatment.
The Study: Tracking 223 Patients Over Two Decades
Researchers at the University of Alberta Hospital analyzed kidney function data from 223 adults who underwent islet transplantation between 1999 and 2018. They used eGFR (estimated glomerular filtration rate)—a standard measure of how well the kidneys filter waste—to track changes over time. The study identified patterns in how quickly kidney function declined and explored whether sex, baseline kidney health, and other factors influenced outcomes.
The Three Phases: How Kidney Function Changes After Transplant
The research revealed a triphasic pattern—three distinct phases of kidney function decline. In the first year after transplantation, kidney function dropped at a rate of about 11.5 ml per minute per 1.73 m² of body surface per year. This is the steepest decline.
Between years 1 and 5, the decline slowed to about 3.1 ml per minute per year. From year 5 to year 20, it slowed further to about 1.1 ml per minute per year. In other words, the biggest stress on the kidneys happens immediately after transplant, but then stabilizes considerably.
Sex Differences in First-Year Kidney Decline
The study found an important difference between men and women. Women experienced a sharper decline in kidney function during the critical first year—about 14.8 ml per minute per year compared to 6.75 ml per minute per year in men. This sex-based difference highlights that immunosuppressive effects may not be uniform across all recipients and suggests the need for personalized monitoring strategies.
Looking Ahead: Why This Matters
These findings come at a time when researchers are actively developing new immunosuppressive approaches that do not rely on calcineurin inhibitors. By documenting the kidney impact of current standard treatment over 20 years, this study provides a clear baseline. It shows that while kidney stress is real and measurable, it stabilizes after the first year—information that helps patients understand both the risks and the realistic long-term outlook of islet transplantation.
For anyone considering islet transplantation or already living with a transplanted islet, this research underscores the importance of regular kidney monitoring and close collaboration with the transplant team to manage immunosuppression and overall health.
Evidence label
Source: Diabetologia. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.
Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.
From Type1Cure
Our own writing on the same ground.
- OriginalType 1 diabetes research watch: recent papers and DOI records worth sortingA daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.
- OriginalType 1 diabetes research watch: recent papers and DOI records worth sortingA daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.
- OriginalType 1 diabetes research watch: recent papers and DOI records worth sortingA daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.
Related reading
More evidence-labeled coverage across the Type1Cure library.
- Research summaryCure & AdvancementsGene-Edited Islets Show Promise, But Long-Term Questions RemainPubMed indexed literature
- Research summaryCure & AdvancementsHow Islet Size Shapes Cell Composition: What Scientists Found in Healthy PancreasesPubMed indexed literature
- Research summaryCure & AdvancementsStem Cell-Derived Islets: A New Research Path Toward Restoring Insulin ProductionPubMed indexed literature
- Research summaryCure & AdvancementsBerberine Shows Promise for Pancreatic Cell Recovery in Type 1 Diabetes ResearchPubMed indexed literature
- Research summaryCure & AdvancementsHow Gut Bacteria May Influence Type 1 Diabetes Risk Through Immune ControlPubMed indexed literature
- Research summaryCure & AdvancementsNew Blood Test May Help Identify Type 1 Diabetes EarlierPubMed indexed literature